PYPD

PolyPid Ltd. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website olypid.com
Employees(FY) -
ISIN IL0011326795

Performance

-9.26%

1W

-10.67%

1M

-34.2%

3M

+1.66%

6M

+13.42%

YTD

-65.3%

1Y

Profile

PolyPid Ltd., a clinical-stage pharmaceutical company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which helps in the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Advanced Technical Analysis

Technical Analysis of PYPD 2024-05-03

Overview:

In analyzing the technical indicators for PYPD over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysi...

See more ...

Recent News & Updates

2024-05-07 19:00
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results(Globenewswire)
2024-04-30 19:00
PolyPid to Participate in Citizens JMP Life Sciences Conference(Globenewswire)
2024-04-29 19:00
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX for the Prevention of Abdominal Colorectal Surgical Site Infections(Globenewswire)
2024-04-23 19:00
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024(Globenewswire)
2024-02-27 18:00
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference(Globenewswire)
2024-02-18 23:00
PolyPid Ltd. (PYPD) Upgraded to Buy: What Does It Mean for the Stock?(Zacks)
2024-02-14 20:41
PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-02-13 18:00
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-02-11 18:00
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial(Globenewswire)
2024-01-30 18:00
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024(Globenewswire)
2024-01-04 03:32
PolyPid Announces Private Placement for $16 Million in Gross Proceeds(Globenewswire)
2023-11-11 21:40
PolyPid Ltd. (NASDAQ:PYPD) Q3 2023 Earnings Call Transcript(Yahoo Finance)
2023-11-07 18:00
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results(Globenewswire)
2023-11-06 18:00
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors(Globenewswire)
2023-10-31 19:00
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023(Globenewswire)
2023-10-10 19:00
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule(Globenewswire)
2023-10-08 19:00
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023(Globenewswire)
2023-10-03 19:00
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX and PLEX Technology Platform(Globenewswire)
2023-09-21 19:00
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference(Yahoo Finance)
2023-09-20 19:34
PolyPid Announces Successful Commercial Good Manufacturing Practice (GMP) Audit by Israeli Ministry of Health(Yahoo Finance)
2023-09-19 21:15
PolyPid Announces Reverse Share Split(Yahoo Finance)
2023-09-18 19:00
PolyPid Announces Successful Completion of Manufacturing Process Validation for D-PLEX(Yahoo Finance)
2023-08-08 19:00
PolyPid Provides Corporate Update and Reports Second Quarter 2023 Financial Results(Yahoo Finance)
2023-07-25 19:00
PolyPid to Report Second Quarter 2023 Financial Results and Operational Highlights on August 9, 2023(Yahoo Finance)
2023-06-28 20:00
PolyPid Announces New Publication Highlighting Potent Antibacterial Activity of D-PLEX against Susceptible and Resistant Bacteria for the Prevention of Surgical Site Infections(Yahoo Finance)
2023-06-21 19:00
PolyPid Announces Recruitment of First Patient in Revised SHIELD II Phase 3 Trial Evaluating D-PLEX for Prevention of Abdominal Colorectal Surgical Site Infections(Yahoo Finance)
2023-06-05 04:02
PolyPid Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement and Transfer of its Listing to the Nasdaq Capital Market(Yahoo Finance)
2023-05-21 21:00
PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX for Prevention of Abdominal Colorectal Surgical Site Infections(Yahoo Finance)
2023-05-13 00:30
PolyPid Ltd. (NASDAQ:PYPD) Q1 2023 Earnings Call Transcript(Yahoo Finance)
2023-05-09 19:00
PolyPid Provides Corporate Update and Reports First Quarter 2023 Financial Results(Yahoo Finance)

Page 1 of 4

previousnext